Form 4 for BNTX BioNTech SE
Accepted 2026-09-18 16:41:36 ET · period of report 2026-09-17 · accession 0002123975-26-000019 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2026-09-18 16:41 | 2026-09-17+ | BNTX | Sahin Ugur | CEO, 10% | S - Sale | $97.49 | -64.0K | 489.2K | -12% | -$6.24M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-09-17 | S | D | 34,000 | $98.60 | 519,209 | D | — | — | |
| 2 | Common | Ordinary Shares | 2026-09-18 | S | D | 30,000 | $96.22 | 489,209 | D | — | — |